Boothbay Fund Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Boothbay Fund Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-92,500	Closed	-$2.29M	–	2814
2022 Q2	$2.29M	Buy	+92,500	New	+$2.04M	0.06%	500
2021 Q4	–	Sell	-81,700	Closed	-$1.4M	–	2391
2021 Q3	$1.4M	Buy	81,700 +55,600	+213%	+$866K	0.04%	601
2021 Q2	$349K	Buy	26,100 +25,862	+10,866%	+$637K	0.01%	1194
2021 Q1	$1.22M	Buy	+238	New	+$14.3K	0.05%	505
2020 Q4	–	Sell	-103	Closed	-$564K	–	1497
2020 Q3	$564K	Buy	+103	New	+$5.54K	0.03%	610
2020 Q2	–	Sell	-162	Closed	-$651K	–	1150
2020 Q1	$651K	Buy	+162	New	+$6.88K	0.05%	409
2019 Q4	–	Sell	-417	Closed	-$283K	–	1056
2019 Q3	$283K	Hold	417	–	–	0.03%	589
2019 Q2	$388K	Buy	+417	New	+$4.83K	0.04%	478

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Boothbay Fund Management's CCXI Position: Q3 2021 in Review

Boothbay Fund Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2021, closing a stake of 53,528 shares — an estimated $834K sold.

Boothbay Fund Management first reported a position in CCXI in Q4 2016 and held it in 4 quarters. The position peaked at $717K in Q2 2021. 140 funds tracked by Wall St. Rank hold CCXI as of Q3 2021.

Boothbay Fund Management reported no remaining ChemoCentryx, Inc. position as of Q3 2021 after selling out during the quarter.
Boothbay Fund Management sold 53,528 ChemoCentryx, Inc. shares in Q3 2021, an estimated $834K.
Boothbay Fund Management first reported a position in ChemoCentryx, Inc. in Q4 2016 and held it in 4 quarters.
Boothbay Fund Management's ChemoCentryx, Inc. position peaked at $717K in Q2 2021.
140 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.